lactic acid has been researched along with Orthomyxoviridae Infections in 6 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Orthomyxoviridae Infections: Virus diseases caused by the ORTHOMYXOVIRIDAE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watkins, HC | 1 |
| Pagan, CL | 1 |
| Childs, HR | 1 |
| Posada, S | 1 |
| Chau, A | 1 |
| Rios, J | 1 |
| Guarino, C | 1 |
| DeLisa, MP | 1 |
| Whittaker, GR | 1 |
| Putnam, D | 1 |
| Hiremath, J | 2 |
| Kang, KI | 2 |
| Xia, M | 1 |
| Elaish, M | 1 |
| Binjawadagi, B | 2 |
| Ouyang, K | 2 |
| Dhakal, S | 2 |
| Arcos, J | 1 |
| Torrelles, JB | 1 |
| Jiang, X | 1 |
| Lee, CW | 2 |
| Renukaradhya, GJ | 2 |
| Bondra, K | 1 |
| Lakshmanappa, YS | 1 |
| Shyu, DL | 1 |
| Goodman, J | 1 |
| Tabynov, K | 1 |
| Krakowka, S | 1 |
| Narasimhan, B | 1 |
| Zhao, K | 1 |
| Li, GX | 1 |
| Jin, YY | 1 |
| Wei, HX | 1 |
| Sun, QS | 1 |
| Huang, TT | 1 |
| Wang, YF | 1 |
| Tong, GZ | 1 |
| Wack, A | 1 |
| Baudner, BC | 1 |
| Hilbert, AK | 1 |
| Manini, I | 1 |
| Nuti, S | 1 |
| Tavarini, S | 1 |
| Scheffczik, H | 1 |
| Ugozzoli, M | 1 |
| Singh, M | 1 |
| Kazzaz, J | 1 |
| Montomoli, E | 1 |
| Del Giudice, G | 1 |
| Rappuoli, R | 1 |
| O'Hagan, DT | 1 |
| Coombes, AG | 1 |
| Major, D | 1 |
| Wood, JM | 1 |
| Hockley, DJ | 1 |
| Minor, PD | 1 |
| Davis, SS | 1 |
6 other studies available for lactic acid and Orthomyxoviridae Infections
| Article | Year |
|---|---|
A single dose and long lasting vaccine against pandemic influenza through the controlled release of a heterospecies tandem M2 sequence embedded within detoxified bacterial outer membrane vesicles.
Topics: Animals; Cell-Derived Microparticles; Delayed-Action Preparations; Female; Humans; Immunoglobulin G; | 2017 |
Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs.
Topics: Animals; Antibodies, Viral; Cell Line; Dogs; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; In | 2016 |
Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs.
Topics: Administration, Intranasal; Animals; Antigens, Viral; Cells, Cultured; Dogs; Immunity, Cellular; Inf | 2017 |
Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres.
Topics: Animals; Cell Line; Cell Proliferation; Cell Survival; DNA; Drug Compounding; Emulsions; Female; Lac | 2010 |
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Antibody Specificity; Calcium Phosphates; Cell L | 2008 |
Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Biocompatible Materials; Drug Delivery Systems; | 1998 |